AGP Picks
View all

Taiwan Sci-Tech Weekly
Provided by AGP

Taiwan Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Taiwan Sci-Tech Weekly.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 4, 2026

Descartes Sets Date to Announce Second Quarter Fiscal 2027 Financial Results
Aug. 4, 2026

Descartes Sets Date to Announce Second Quarter Fiscal 2027 Financial Results

Indeterminate GlobeNewswire
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Aug. 4, 2026

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Indeterminate GlobeNewswire
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
Aug. 4, 2026

Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
Aug. 4, 2026

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Indeterminate GlobeNewswire
iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
Aug. 4, 2026

iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer

Indeterminate GlobeNewswire
Shoals Technologies Group, Inc. Reports Financial Results for Second Quarter 2026
Aug. 4, 2026

Shoals Technologies Group, Inc. Reports Financial Results for Second Quarter 2026

Indeterminate GlobeNewswire
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
Aug. 4, 2026

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Indeterminate GlobeNewswire
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
Aug. 4, 2026

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Indeterminate GlobeNewswire
Aeluma Names Jason Taylor Senior Director of Program and Project Management
Aug. 4, 2026

Aeluma Names Jason Taylor Senior Director of Program and Project Management

Indeterminate GlobeNewswire
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 4, 2026

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 4, 2026

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Certara Reports Second Quarter 2026 Financial Results
Aug. 4, 2026

Certara Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases
Aug. 4, 2026

Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases

Indeterminate GlobeNewswire
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
Aug. 4, 2026

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

Indeterminate GlobeNewswire
Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader
Aug. 4, 2026

Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader

Indeterminate GlobeNewswire
Encore Technologies Completes Oversubscribed Private Placement and Increases Strategic Investment in Solstar Space Company
Aug. 4, 2026

Encore Technologies Completes Oversubscribed Private Placement and Increases Strategic Investment in Solstar Space Company

Indeterminate GlobeNewswire
Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs
Aug. 4, 2026

Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Aug. 4, 2026

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Indeterminate GlobeNewswire
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy
Aug. 4, 2026

Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
Aug. 4, 2026

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Taiwan Sci-Tech Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.